DEVELOPING SARCOPENIA IS A RISK FACTOR FOR FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS: 4-YEAR DATA FROM THE CHIKARA STUDY

被引：0
|
作者：
Yamada, Y. [1 ]
Tada, M. [2 ]
Mandai, K. [3 ]
Hidaka, N. [2 ]
Nakamura, H. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan
[2] Osaka City Gen Hosp, Dept Orthoped Surg, Osaka, Japan
[3] Saiseikai Nakatsu Hosp, Dept Orthoped Surg, Osaka, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.277
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0813
引用
收藏
页码：1431 / 1431
页数：1
相关论文
共 50 条
  • [1] Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study
    Yamada, Yutaro
    Tada, Masahiro
    Mandai, Koji
    Hidaka, Noriaki
    Inui, Kentaro
    Nakamura, Hiroaki
    CLINICAL RHEUMATOLOGY, 2020, 39 (06) : 1757 - 1764
  • [2] Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study
    Yutaro Yamada
    Masahiro Tada
    Koji Mandai
    Noriaki Hidaka
    Kentaro Inui
    Hiroaki Nakamura
    Clinical Rheumatology, 2020, 39 : 1757 - 1764
  • [3] RISK FACTORS FOR DEVELOPING SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS AT 2 YEARS: FROM THE CHIKARA STUDY
    Yamada, Yutaro
    Tada, Masahiro
    Mandai, Koji
    Hidaka, Noriaki
    Inui, Kentaro
    Nakamura, Hiroaki
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 352 - 353
  • [4] GLUCOCORTICOID USE IS AN INDEPENDENT RISK FACTOR FOR SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS - FROM THE CHIKARA STUDY
    Yamada, Y.
    Tada, M.
    Mandai, K.
    Hidaka, N.
    Inui, K.
    Nakamura, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 308 - 309
  • [5] ANALYSIS OF RISK FACTOR FOR LOCOMOTIVE SYNDROME IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM CHIKARA STUDY
    Yamada, Y.
    Tada, M.
    Mandai, K.
    Hidaka, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1178 - 1179
  • [6] PATIENTS WITH RHEUMATOID ARTHRITIS WHO DEVELOP SARCOPENIA FALL FREQUENTLY: 5-YEAR DATA FROM THE CHIKARA STUDY
    Yamada, Y.
    Tada, M.
    Mandai, K.
    Hidaka, N.
    Nakamura, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1257 - 1258
  • [7] SARCOPENIA COULD NOT PREDICT FALLS IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE CHIKARA STUDY
    Tada, M.
    Yamada, Y.
    Mandai, K.
    Hidaka, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1356 - 1356
  • [8] RELATIONSHIP OF MATRIX METALLOPROTEASE 3 TITER AND SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE CHIKARA STUDY
    Tada, M.
    Yamada, Y.
    Mandai, K.
    Hidaka, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 260 - 260
  • [9] A LONGITUDINAL STUDY OF SARCOPENIA, LOCOMOTIVE SYNDROME, AND FRAILTY IN PATIENTS WITH RHEUMATOID ARTHRITIS: FROM THE CHIKARA STUDY
    Mandai, K.
    Tada, M.
    Yamada, Y.
    Koike, T.
    Okano, T.
    Hidaka, N.
    Nakamura, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 492 - 492
  • [10] Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis - results from the CHIKARA study
    Tada, Masahiro
    Yamada, Yutaro
    Mandai, Koji
    Hidaka, Noriaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (11) : 1962 - 1969
12345